MRI/US Fusion Improves PCa Detection

Florida Urological Society's 68th annual meeting -- Targeted biopsy techniques combining magnetic resonance imaging (MRI) and ultrasound can improve detection of significant prostate cancer (PCa) and could influence development of future criteria for active surveillance, according to a researcher.

Pay Gap Due to Coding Differences?

A study suggests that female physicians do not use as many codes as their male counterparts, resulting in a reimbursement gap.

Sexual Problems Linked to 5ARI Use ...

Use of 5α-reductase inhibitors (5ARIs) to treat benign prostatic hyperplasia (BPH) is associated with a significantly increased risk of sexual dysfunction.

Information Breaches Lead to Lawsuits

Providers can be sued under state rules pertaining to privacy and negligence for breaches.

Hypogonadism Linked to Poor ESA Response

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), reduced muscle mass, and lower levels of physical activity are associated with a greater likelihood of hypogonadism in men undergoing hemodialysis (HD).

PAE: Promising BPH Treatment

Florida Urological Society's 68th annual meeting: Prostate artery embolization (PAE) has been emerging as a minimally invasive alternative for patients suffering from benign prostatic hyperplasia (BPH).

Latest Assays Can Improve PCa Workup

Florida Urological Society's 68th annual meeting: New assays and scoring systems can improve the accuracy of prostate cancer (PCa) screening, prognostication, and risk stratification compared with the use of PSA alone.

Improve Cancer Screening for Transplant Recipients

Existing cancer screening guidelines for solid organ transplant recipients fall short in several key ways, according to a new review.

Hepatitis C in CKD: Challenges, Opportunities

Annette Bruchfeld, MD, PhD, discusses chronic HCV infection in the contexts of chronic kidney disease, dialysis, and transplantation.

CME: SGLT-2 Inhibitors for Type 2 ...

Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.

Sign Up for Free e-newsletters